The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis
Open accessAbstract
Tuberculosis (TB), caused by infection with Mycobacterium tuberculosis, is a major cause of morbidity and mortality worldwide. Efforts to control it are hampered by difficulties with diagnosis, prevention and treatment. Most people infected with M. tuberculosis remain asymptomatic, termed latent TB, with a 10% lifetime risk of developing active TB disease. Current tests, however, cannot identify which individuals will develop disease. The immune response to M. tuberculosis is complex and incompletely characterized, hindering development of new diagnostics, therapies and vaccines. Here we identify a whole-blood 393 transcript signature for active TB in intermediate and high-burden settings, correlating with radiological extent of disease and reverting to that of healthy controls after treatment. A subset of patients with latent TB had signatures similar to those in patients with active TB. We also identify a specific 86-transcript signature that discriminates active TB from other inflammatory and infectious diseases. Modular and pathway analysis revealed that the TB signature was dominated by a neutrophil-driven interferon (IFN)-inducible gene profile, consisting of both IFN-gamma and type I IFN-alphabeta signalling. Comparison with transcriptional signatures in purified cells and flow cytometric analysis suggest that this TB signature reflects changes in cellular composition and altered gene expression. Although an IFN-inducible signature was also observed in whole blood of patients with systemic lupus erythematosus (SLE), their complete modular signature differed from TB, with increased abundance of plasma cell transcripts. Our studies demonstrate a hitherto underappreciated role of type I IFN-alphabeta signalling in the pathogenesis of TB, which has implications for vaccine and therapeutic development. Our study also provides a broad range of transcriptional biomarkers with potential as diagnostic and prognostic tools to combat the TB epidemic.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Therefore, it is no surprise that IFN-β transcriptome signatures were found to be associated with active but not latent TB (101).”
From Macrophage defense mechanisms against intracellular bacteria (2015) · cites this paper as [101]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Baechler, E. C., Batliwalla, F., Karypis, G., Gaffney, P. M., Ortmann, W. A., Espe, K. J., Shark, K. B., Grande, W. J., Hughes, K. M. H., Kapur, V., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0337679100 · Cited by 2,246
Interferon and Granulopoiesis Signatures in Systemic Lupus Erythematosus Blood
Bennett, L. B., Palucka, K., Arce, E., Cantrell, V., Borvák, J., Banchereau, J., & Pascual, V. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021553 · Cited by 1,990
Self-citationBlood Monocytes: Development, Heterogeneity, and Relationship with Dendritic Cells
Auffray, C., Sieweke, M. H., & Geissmann, F. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132557 · Cited by 1,744
The spectrum of latent tuberculosis: rethinking the biology and intervention strategies
Barry, C. E., Boshoff, H. I., Dartois, V. A., Dick, T., Ehrt, S., Flynn, J. L., Schnappinger, D., Wilkinson, R. J., & Young, D. B. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2236 · Cited by 1,441
Self-citationCell-Mediated Immune Responses in Tuberculosis
Cooper, A. M. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132703 · Cited by 1,194
Flynn, J., & Chan, J. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.93 · Cited by 1,144
Genetic Dissection of Immunity to Mycobacteria: The Human Model
Casanova, J., & Abel, L. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.081501.125851 · Cited by 1,006
A Modular Analysis Framework for Blood Genomics Studies: Application to Systemic Lupus Erythematosus
Chaussabel, D., Quinn, C., Shen, J., Patel, P., Glaser, C., Baldwin, N., Stichweh, D., Blankenship, D., Li, L., Munagala, I., et al. (2008) · Immunity · doi:10.1016/j.immuni.2008.05.012 · Cited by 649
Self-citationImmunisation against infectious disease
SALISBURY, D. M., Ramsay, M. E., & Noakes, K. (2006) · Stationery Office eBooks · Cited by 636
Newsom, S. W. B. (2006) · Journal of Hospital Infection · doi:10.1016/j.jhin.2006.06.003 · Cited by 636
Flagged first, then by citations
Research works printed but not linked: 2
- Dye, C., Floyd, K. & Uplekar, M. in Global Tuberculosis Control: Surveillance, Planning, Financing Ch. 1, 17–37 (World Health Organization, 2008)
- Falk, A. & O’Connor, J. B. in Diagnosis Standards and Classification of Tuberculosis, vol. 12 (eds Falk, A. et al.), 68–76 (National Tuberculosis and Respiratory Disease Association, 1969)
Cited by
Sorted by citations
Items 501–600 of 1,000
Targeting immunometabolism in host defence against Mycobacterium tuberculosis
Sheedy, F. J., & Divangahi, M. (2020) · Immunology · doi:10.1111/imm.13276 · Cited by 62
Immune regulation of Rab proteins expression and intracellular transport
Pei, G., Bronietzki, M., & Gutierrez, M. G. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.0212076 · Cited by 62
An interactive web application for the dissemination of human systems immunology data
Speake, C., Presnell, S., Domico, K., Zeitner, B., Bjork, A., Anderson, D., Mason, M. J., Whalen, E., Vargas, O., Popov, D., et al. (2015) · Journal of Translational Medicine · doi:10.1186/s12967-015-0541-x · Cited by 59
Self-citationPlatelet Activation and the Immune Response to Tuberculosis
Kirwan, D. E., Chong, D. L. W., & Friedland, J. S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.631696 · Cited by 58
Lu, J., Kerns, R. T., Peddada, S. D., & Bushel, P. R. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr241 · Cited by 58
Early IFN type I response: Learning from microbial evasion strategies
Coccia, E. M., & Battistini, A. (2015) · Seminars in Immunology · doi:10.1016/j.smim.2015.03.005 · Cited by 59
Spleen-derived IFN-γ induces generation of PD-L1+-suppressive neutrophils during endotoxemia
Langereis, J. D., Pickkers, P., de Kleijn, S., Gerretsen, J., de Jonge, M. I., & Kox, M. (2017) · Journal of Leukocyte Biology · doi:10.1189/jlb.3a0217-051rr · Cited by 63
Miyahara, R., Piyaworawong, S., Naranbhai, V., Prachamat, P., Kriengwatanapong, P., Tsuchiya, N., Wongyai, J., Bupachat, S., Yamada, N., Summanapan, S., et al. (2019) · BMC Infectious Diseases · doi:10.1186/s12879-019-4292-9 · Cited by 58
Whole-blood transcriptomic responses to lumacaftor/ivacaftor therapy in cystic fibrosis
Kopp, B. T., Fitch, J., Jaramillo, L., Shrestha, C. L., Robledo-Avila, F. H., Zhang, S., PALACIOS, S. K., Woodley, F. W., Hayes, D., Partida‐Sánchez, S., et al. (2019) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2019.08.021 · Cited by 60
Self-citationKurtz, S. L., Rossi, A. P., Beamer, G., Gatti, D. M., Kramnik, I., & Elkins, K. L. (2020) · mSphere · doi:10.1128/msphere.00097-20 · Cited by 63
Lin, Z., Leung, E., Lee, N. L. S., Lui, G. C.-Y., To, K., Chan, R. C. Y., & Ip, M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0126018 · Cited by 58
Leong, S., Zhao, Y., Joseph, N. M., Hochberg, N. S., Sarkar, S., Pleskunas, J., Hom, D. L., Lakshminarayanan, S., Horsburgh, C. R., Roy, G., et al. (2018) · Tuberculosis · doi:10.1016/j.tube.2018.01.002 · Cited by 60
M. tuberculosisinfection of human iPSDM reveals complex membrane dynamics during xenophagy evasion
Bernard, E. M., Fearns, A., Bussi, C., Santucci, P., Peddie, C. J., Lai, R., Collinson, L., & Gutierrez, M. G. (2020) · Journal of Cell Science · doi:10.1242/jcs.252973 · Cited by 60
Hoang, L. T., Jain, P., Pillay, T. D., Tolosa-Wright, M., Niazi, U. H. K., Takwoingi, Y., Halliday, A., Berrocal-Almanza, L. C., Deeks, J. J., Beverley, P. C. L., et al. (2021) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30928-2 · Cited by 57
Self-citationImmunophenotyping assessment in a COVID-19 cohort (IMPACC): A prospective longitudinal study
IMPACC Manuscript Writing Team, Rouphael, N., Maecker, H. T., Montgomery, R. R., Diray‐Arce, J., Kleinstein, S. H., Altman, M. C., Bosinger, S. E., Eckalbar, W. L., Guan, L., et al. (2021) · Science Immunology · doi:10.1126/sciimmunol.abf3733 · Cited by 58
Neutrophil Dynamics Affect Mycobacterium tuberculosis Granuloma Outcomes and Dissemination
Hult, C., Mattila, J. T., Gideon, H. P., Linderman, J. J., & Kirschner, D. E. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.712457 · Cited by 57
Transcriptional specialization of human dendritic cell subsets in response to microbial vaccines
Banchereau, R., Baldwin, N. E., Cepika, A., Athale, S., Xue, Y., Yu, C. I., Metang, P., Cheruku, A., Berthier, I., Gayet, I., et al. (2014) · Nature Communications · doi:10.1038/ncomms6283 · Cited by 62
Self-citationMasood, K. I., Rottenberg, M. E., Salahuddin, N., Irfan, M., Rao, N. A., Carow, B., Islam, M., Hussain, R., & Hasan, Z. (2013) · BMC Infectious Diseases · doi:10.1186/1471-2334-13-13 · Cited by 58
Ploquin, M. J.-Y., Madec, Y., Casrouge, A., Huot, N., Passaes, C., Lécuroux, C., Essat, A., Boufassa, F., Jacquelin, B., Jochems, S. P., et al. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005774 · Cited by 57
Complex regulation of neutrophil-derived MMP-9 secretion in central nervous system tuberculosis
Ong, C. W. M., Pabisiak, P. J., Brilha, S., Singh, P., Roncaroli, F., Elkington, P. T., & Friedland, J. S. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0801-1 · Cited by 58
Tiwari, S., Casey, R., Goulding, C. W., Hingley‐Wilson, S., & Jacobs, W. R. (2019) · Microbiology Spectrum · doi:10.1128/microbiolspec.bai-0024-2019 · Cited by 61
The microbiome at the pulmonary alveolar niche and its role in Mycobacterium tuberculosis infection
Adami, A. J., & Cervantes, J. (2015) · Tuberculosis · doi:10.1016/j.tube.2015.07.004 · Cited by 56
A single-cell view on host immune transcriptional response to in vivo BCG-induced trained immunity
Li, W., Moorlag, S. J. C. F. M., Koeken, V. A. C. M., Röring, R. J., de Bree, L. C. J., Mourits, V. P., Gupta, M. K., Zhang, B., Fu, J., Zhang, Z., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112487 · Cited by 56
Immunopathology in human tuberculosis
Scriba, T. J., Maseeme, M., Young, C., Taylor, L. J., & Leslie, A. J. (2024) · Science Immunology · doi:10.1126/sciimmunol.ado5951 · Cited by 57
Gorvel, L., Textoris, J., Banchereau, R., Amara, A. B., Tantibhedhyangkul, W., von Bargen, K., Ka, M. B., Capo, C., Ghigo, É., Gorvel, J., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099420 · Cited by 56
Self-citationTB or Not TB: That Is No Longer the Question
Modlin, R. L., & Bloom, B. R. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3007402 · Cited by 58
Walter, N. D., Miller, M. A., Vasquez, J., WEINER, M. H., Chapman, A., Engle, M., Higgins, M. P., Quinones, A., Rosselli, V., Canono, E., et al. (2015) · Journal of Clinical Microbiology · doi:10.1128/jcm.01990-15 · Cited by 56
Meta-analysis of host response networks identifies a common core in tuberculosis
Sambarey, A., Devaprasad, A., Baloni, P., Mishra, M., Mohan, A., Tyagi, P., Singh, A., Akshata, J. S., Sultana, R., Buggi, S., et al. (2017) · npj Systems Biology and Applications · doi:10.1038/s41540-017-0005-4 · Cited by 56
Omae, Y., Toyo-oka, L., Yanai, H., Nedsuwan, S., Wattanapokayakit, S., Satproedprai, N., Smittipat, N., Palittapongarnpim, P., Sawanpanyalert, P., Inunchot, W., et al. (2017) · Journal of Human Genetics · doi:10.1038/jhg.2017.82 · Cited by 57
Herman, P. E., Stein, A., Gibbs, K., Korsunsky, I., Gregersen, P. K., & Bloom, O. (2018) · Journal of Neurotrauma · doi:10.1089/neu.2017.5519 · Cited by 56
Kim, B.-R., Kim, B.-J., Kook, Y., & Kim, B. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00125 · Cited by 56
Immunometabolic Signatures Predict Risk of Progression to Active Tuberculosis and Disease Outcome
Duffy, F. J., Weiner, J. M., Hansen, S. G., Tabb, D. L., Suliman, S., Thompson, E. G., Maertzdorf, J., Shankar, S., Tromp, G., Parida, S. K., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00527 · Cited by 57
TRIM14 Is a Key Regulator of the Type I IFN Response during Mycobacterium tuberculosis Infection
Hoffpauir, C. T., Bell, S. L., West, K. O., Jing, T., Wagner, A. R., Torres-Odio, S., Cox, J. S., West, A. P., Li, P., Patrick, K. L., et al. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.1901511 · Cited by 55
Huang, T.-H., Uthe, J. J., Bearson, S. M. D., Demirkale, C. Y., Nettleton, D. S., Knetter, S., Christian, C., Ramer‐Tait, A. E., Wannemuehler, M. J., & Tuggle, C. K. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028768 · Cited by 55
Guerreiro, L. T. A., Ferreira, A. B. R., Alves, M. R., de Toledo-Pinto, T. G., Brito, T. R., Rosa, P. S., Sandoval, F., Jardim, M. R., Antunes, S. L. G., Shannon, E. J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064748 · Cited by 55
Doz, E., Lombard, R., Carreras, F., Buzoni–Gatel, D., & Winter, N. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300527 · Cited by 56
Increased CXC Ligand 10 Levels and Gene Expression in Type 1 Leprosy Reactions
Scollard, D. M., Chaduvula, M. V., Martinez, A. N., Fowlkes, N. W., Nath, I., Stryjewska, B. M., Kearney, M. T., & Williams, D. L. (2011) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00042-11 · Cited by 55
for the Rede-TB Study group, Mesquita, E. D. D., Gil-Santana, L., Ramalho, D. M. D. P., Tonomura, E., Silva, E., Oliveira, M. M., Andrade, B. B., & Kritski, A. L. (2016) · BMC Infectious Diseases · doi:10.1186/s12879-016-1736-3 · Cited by 60
The impact of ISGylation during Mycobacterium tuberculosis infection in mice
Kimmey, J. M., Campbell, J. A., Weiss, L. A., Monte, K. J., Lenschow, D. J., & Stallings, C. L. (2017) · Microbes and Infection · doi:10.1016/j.micinf.2016.12.006 · Cited by 56
OAS1, OAS2 and OAS3 restrict intracellular M. tb replication and enhance cytokine secretion
Leisching, G. R., Cole, V., Ali, A. T., & Baker, B. (2019) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2019.02.029 · Cited by 55
Chai, Q., Lü, Z., Liu, Z., Zhong, Y., Zhang, F., Qiu, C., Li, B., Wang, J., Zhang, L., Pang, Y., et al. (2020) · Communications Biology · doi:10.1038/s42003-020-01318-0 · Cited by 55
Single-cell immune profiling reveals functional diversity of T cells in tuberculous pleural effusion
Cai, Y., Wang, Y., Shi, C., Dai, Y., Li, F., Xu, Y., Zhang, P., Kong, F., Deng, G., Wen, Z., et al. (2022) · The Journal of Experimental Medicine · doi:10.1084/jem.20211777 · Cited by 56
IFNγ‐producing CD4+ T lymphocytes: the double‐edged swords in tuberculosis
Kumar, P. (2017) · Clinical and Translational Medicine · doi:10.1186/s40169-017-0151-8 · Cited by 57
Targeting neutrophils for host-directed therapy to treat tuberculosis
Dallenga, T. K., Linnemann, L. C., Paudyal, B., Repnik, U., Griffiths, G. W., & Schaible, U. E. (2017) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2017.10.001 · Cited by 54
Nakaya, H. I., & Pulendran, B. (2011) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e32834dc37b · Cited by 53
Prišić, S., Hwang, H., Dow, A., Barnaby, O. S., Pan, T. S., Lonzanida, J. A., Chazin, W., Steen, H., & Husson, R. N. (2015) · Molecular Microbiology · doi:10.1111/mmi.13022 · Cited by 53
Perspectives for personalized therapy for patients with multidrug‐resistant tuberculosis
Lange, C. G., Alghamdi, W. A., Al‐Shaer, M. H., Brighenti, S., Diacon, A. H., DiNardo, A. R., Grobbel, H.-P., Gröschel, M. I., von Groote-Bidlingmaier, F., Hauptmann, M., et al. (2018) · Journal of Internal Medicine · doi:10.1111/joim.12780 · Cited by 53
Vinhaes, C. L., Oliveira-de-Souza, D., Silveira-Mattos, P. S., Nogueira, B. M. F., Shi, R., Wei, W., Yuan, X., Zhang, G., Cai, Y., Barry, C. E., et al. (2019) · Cytokine · doi:10.1016/j.cyto.2019.154759 · Cited by 53
Gliddon, H. D., Kaforou, M., Alikian, M., Habgood-Coote, D., Zhou, C., Oni, T., Anderson, S. T. B., Brent, A., Crampin, A. C., Eley, B., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.637164 · Cited by 53
Self-citationBloom, C. I., Graham, C. M., Berry, M. P. R., Rozakeas, F., Redford, P. S., Wang, Y., Xu, Z., Wilkinson, K. A., Wilkinson, R. J., Kendrick, Y., et al. (2013) · PLoS ONE · doi:10.1371/annotation/7d9ec449-aee0-48fe-8111-0c110850c0c1 · Cited by 53
Self-citationImmunologic, metabolic and genetic impact of diabetes on tuberculosis susceptibility
Ssekamatte, P., Sande, O. J., van Crevel, R., & Biraro, I. A. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1122255 · Cited by 52
Diagnosis and biomarkers for ocular tuberculosis: From the present into the future
Ludi, Z., Sule, A. A., Samy, R. P., Putera, I., Schrijver, B., Hutchinson, P. E., Gunaratne, J., Verma, I., Singhal, A., Nora, R. L. D., et al. (2023) · Theranostics · doi:10.7150/thno.81488 · Cited by 52
Mai, D., Jahn, A. N., Murray, T. A., Morikubo, M., Lim, P. N., Cervantes, M. M., Pham, L. K., Nemeth, J., Urdahl, K. B., Diercks, A. H., et al. (2024) · PLoS Pathogens · doi:10.1371/journal.ppat.1011871 · Cited by 54
Dutta, N. K., Illei, P. B., Jain, S. K., & Karakousis, P. C. (2014) · American Journal Of Pathology · doi:10.1016/j.ajpath.2014.03.008 · Cited by 52
In Vivo Molecular Dissection of the Effects of HIV-1 in Active Tuberculosis
Bell, L. C. K., Pollara, G., Mellissa, P., Tomlinson, G. S., Lehloenya, R. J., Roe, J. K., Meldau, R., Miller, R. F., Ramsay, A. D., Chain, B., et al. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005469 · Cited by 52
Avraham, R., Haseley, N., Fan, A. C., Bloom‐Ackermann, Z., Livny, J., & Hung, D. T. (2016) · Nature Protocols · doi:10.1038/nprot.2016.090 · Cited by 52
Beyond Killing Mycobacterium tuberculosis: Disease Tolerance
Divangahi, M., Khan, N., & Kaufmann, E. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02976 · Cited by 53
Role of Glutamine Metabolism in Host Defense Against Mycobacterium tuberculosis Infection
Koeken, V. A. C. M., Lachmandas, E., Riza, A. L., Matzaraki, V., Li, Y., Kumar, V., Oosting, M., Joosten, L. A. B., Netea, M. G., & van Crevel, R. (2018) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiy709 · Cited by 52
Interferons: Tug of War Between Bacteria and Their Host
Alphonse, N., Dickenson, R. E., & Odendall, C. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.624094 · Cited by 52
Gene expression profiles in peripheral blood for the diagnosis of autoimmune diseases
Meskó, B., Póliska, S., & Nagy, L. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.12.004 · Cited by 52
Gajanayaka, N., Dong, S. X. M., Ali, H., Iqbal, S., Mookerjee, A., Lawton, D., Caballero, R. E., Cassol, E., Cameron, D. W., Angel, J. B., et al. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2001191 · Cited by 51
Wang, F., Peters, R. S., Jia, J., Mudd, M. H., Salemi, M., Allers, L., Javed, R., Duque, T. L. A., Paddar, M. A., Trosdal, E. S., et al. (2023) · Developmental Cell · doi:10.1016/j.devcel.2023.03.014 · Cited by 51
Grant, A. V., Baghdadi, J. E., Sabri, A., Azbaoui, S. E., Alaoui-Tahiri, K., Rhorfi, I. A., Gharbaoui, Y., Abid, A., Benkirane, M., Raharimanga, V., et al. (2013) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2013.01.013 · Cited by 54
Sharma, S., Jin, Z., Rosenzweig, E., Rao, S., Ko, K., & Niewold, T. B. (2015) · Journal of Autoimmunity · doi:10.1016/j.jaut.2015.04.002 · Cited by 51
Kasprowicz, V. O., Churchyard, G., Lawn, S. D., Squire, S. B., & Lalvani, A. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir449 · Cited by 51
A 380-gene meta-signature of active tuberculosis compared with healthy controls
Blankley, S., Graham, C. M., Levin, J., Turner, J., Berry, M. P. R., Bloom, C. I., Xu, Z., Pascual, V., Banchereau, J., Chaussabel, D., et al. (2016) · European Respiratory Journal · doi:10.1183/13993003.02121-2015 · Cited by 51
Self-citationGardinassi, L. G., Garcia, G. R., Costa, C. H. N., Silva, V. C., & Santos, I. K. F. D. M. (2016) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0005123 · Cited by 52
Darboe, F., Mbandi, S. K., Thompson, E. G., Fisher, M., Rodo, M., van Rooyen, M., Filander, E., Bilek, N., Mabwe, S., Hatherill, M., et al. (2017) · Tuberculosis · doi:10.1016/j.tube.2017.11.001 · Cited by 51
Integrated, multicohort analysis reveals unified signature of systemic lupus erythematosus
Haynes, W. A., Haddon, D. J., Diep, V. K., Khatri, A., Bongen, E., Yiu, G., Balboni, I., Bolen, C. R., Mao, R., Utz, P. J., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.122312 · Cited by 53
Maertzdorf, J., Weiner, J. M., & Kaufmann, S. H. E. (2012) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.12.0246 · Cited by 50
Interferon Alpha Treatment of Patients with Impaired Interferon Gamma Signaling
Bax, H. I., Freeman, A. F., Ding, L., Hsu, A. P., Marciano, B. E., Kristosturyan, E., Jancel, T., Spalding, C. D., Pechacek, J., Olivier, K. N., et al. (2013) · Journal of Clinical Immunology · doi:10.1007/s10875-013-9882-5 · Cited by 50
Immunodiagnosis of Tuberculosis: State of the Art
Pinto, L., Grenier, J., Schumacher, S. G., Denkinger, C. M., Steingart, K. R., & Pai, M. (2011) · Medical Principles and Practice · doi:10.1159/000331583 · Cited by 50
Andrade, B. B., Kumar, N. P., Sridhar, R., Banurekha, V. V., Jawahar, M. S., Nutman, T. B., Sher, A., & Babu, S. (2014) · CHEST Journal · doi:10.1378/chest.13-1799 · Cited by 50
Novel transcriptional signatures for sputum-independent diagnostics of tuberculosis in children
Gjøen, J. E., Jenum, S., Sivakumaran, D., Mukherjee, A., Macaden, R., Kabra, S. K., Lodha, R., Ottenhoff, T. H. M., Haks, M. C., Doherty, T. M., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-05057-x · Cited by 50
Neutrophil extracellular trap (NET) levels in human plasma are associated with active TB
Schechter, M. C., Buac, K., Adékambi, T., Cagle, S., Celli, J., Ray, S. M., Mehta, C. C., Rada, B., & Rengarajan, J. (2017) · PLoS ONE · doi:10.1371/journal.pone.0182587 · Cited by 50
Yan, S., Shen, H., Lian, Q., Jin, W., Zhang, R., Lin, X., Gu, W., Sun, X., Meng, G., Tian, Z., et al. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1701177 · Cited by 50
Barry, S. E., Ellis, M. K., Yang, Y. R., Guan, G., Wang, X., Britton, W. J., & Saunders, B. M. (2018) · Journal of Infection · doi:10.1016/j.jinf.2018.03.006 · Cited by 50
Genetic Resistance to Mycobacterium tuberculosis Infection and Disease
Möller, M., Kinnear, C. J., Orlova, M., Kroon, E. E., van Helden, P. D., Schurr, E., & Hoal, E. G. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02219 · Cited by 53
Antibody Subclass and Glycosylation Shift Following Effective TB Treatment
Grace, P. S., Dolatshahi, S., Lu, L. L., Cain, A., Palmieri, F., Petrone, L., Fortune, S. M., Ottenhoff, T. H. M., Lauffenburger, D. A., Goletti, D., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.679973 · Cited by 50
Larsen, S. E., Williams, B. D., Rais, M., Coler, R. N., & Baldwin, S. L. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.840225 · Cited by 51
Update on tuberculosis: TB in the early 21st century
Connell, D. W., Berry, M. P. R., Cooke, G., & Kon, O. M. (2011) · European Respiratory Review · doi:10.1183/09059180.00000511 · Cited by 49
Self-citationImmunosuppressive Mechanisms in Brucellosis in Light of Chronic Bacterial Diseases
Pellegrini, J. M., Gorvel, J., & Mémet, S. (2022) · Microorganisms · doi:10.3390/microorganisms10071260 · Cited by 49
Role of Interferons in Mycobacterium tuberculosis Infection
Shanmuganathan, G., Orujyan, D., Narinyan, W., Poladian, N., Dhama, S., Parthasarathy, A., Ha, A., Tran, D., Velpuri, P., Nguyen, K., et al. (2022) · Clinics and Practice · doi:10.3390/clinpract12050082 · Cited by 53
Circulating cell-free RNA in blood as a host response biomarker for detection of tuberculosis
Chang, A., Loy, C., Eweis-LaBolle, D., Lenz, J. S., Steadman, A. E., Andgrama, A., Nhung, N. V., Yu, C. Y., Worodria, W. O., Denkinger, C. M., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-49245-6 · Cited by 49
Defective innate immunity in inflammatory bowel disease: a Crohnʼs disease exclusivity?
Marks, D. J. (2011) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e3283463b45 · Cited by 49
Systems-Level Analysis of Innate Immunity
Zak, D. E., Tam, V. C., & Aderem, A. A. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120254 · Cited by 49
The integrated stress response mediates necrosis in murine Mycobacterium tuberculosis granulomas
Bhattacharya, B., Xiao, S., Chatterjee, S., Urbanowski, M. E., Ordoñez, A. A., Ihms, E. A., Agrahari, G., Lun, S., Berland, R., Pichugin, A. V., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci130319 · Cited by 50
CXCL1: A new diagnostic biomarker for human tuberculosis discovered using Diversity Outbred mice
Koyuncu, D., Niazi, M. K. K., Tavolara, T. E., Abeijón, C., Ginese, M. L., Liao, Y., Mark, C., Specht, A. G., Gower, A. C., Restrepo, B. I., et al. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009773 · Cited by 49
Hare, N. J., Chan, B., Chan, E. D., Alexander, K. L., Britton, W. J., & Saunders, B. M. (2015) · PROTEOMICS · doi:10.1002/pmic.201400610 · Cited by 48
The Top Five “Game Changers” in Vaccinology: Toward Rational and Directed Vaccine Development
Kennedy, R. B., & Poland, G. A. (2011) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2011.0012 · Cited by 48
Artyomov, M. N., Munk, A., Gorvel, L., Korenfeld, D., Cella, M., Tung, T., & Klechevsky, E. (2015) · The Journal of Experimental Medicine · doi:10.1084/jem.20131675 · Cited by 48
Swindells, S., Siccardi, M., Barrett, S. E., Olsen, D. B., Grobler, J. A., Podany, A. T., Nuermberger, E. L., Kim, P., Barry, C. E., Owen, A., et al. (2018) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.17.0486 · Cited by 48
Sun, H., Pan, L., Jia, H., Zhang, Z., Gao, M., Huang, M., Wang, J., Sun, Q., Wei, R., Du, B., et al. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01267 · Cited by 48
Pathogenesis of ocular tuberculosis: New observations and future directions
Basu, S., Elkington, P. T., & Rao, N. A. (2020) · Tuberculosis · doi:10.1016/j.tube.2020.101961 · Cited by 48
Perspectives and Advances in the Understanding of Tuberculosis
Kinsella, R. L., Zhu, D. X., Harrison, G. A., Bridwell, A. E. M., Prusa, J., Chavez, S. M., & Stallings, C. L. (2021) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-042120-032916 · Cited by 51
A half-century of research on tuberculosis: Successes and challenges
Bloom, B. R. (2023) · The Journal of Experimental Medicine · doi:10.1084/jem.20230859 · Cited by 47
Diagnosis of childhood febrile illness using a multi-class blood RNA molecular signature
Habgood-Coote, D., Wilson, C. A., Shimizu, C., Barendregt, A. M., Philipsen, R. L. A., Galassini, R., Calle, I. R., Workman, L., Agyeman, P., Ferwerda, G., et al. (2023) · Med · doi:10.1016/j.medj.2023.06.007 · Cited by 48
Dauphinee, S. M., Richer, É., Eva, M. A., McIntosh, F. A., Paquet, M., Dangoor, D., Burkart, C., Zhang, D.-E., Gruenheid, S., Gros, P., et al. (2014) · Genes and Immunity · doi:10.1038/gene.2014.17 · Cited by 49
Emerging Trends in the Formation and Function of Tuberculosis Granulomas
Lugo‐Villarino, G., Hudrisier, D., Bénard, A., & Neyrolles, O. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00405 · Cited by 47
Current understanding of the immune response to tuberculosis in children
Roy, R. B., Whittaker, E., & Kampmann, B. (2012) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e3283529af9 · Cited by 47
Metadata
- Authors
- Berry, M. P. R., Graham, C. M., McNab, F. W., Xu, Z., Bloch, S. A. A., Oni, T., Wilkinson, K. A., Banchereau, R., Skinner, J., Wilkinson, R. J., Quinn, C., Blankenship, D., Dhawan, R., Cush, J. J., Mejias, A., Ramilo, O., Kon, O. M., Pascual, V., Banchereau, J., Chaussabel, D., & O’Garra, A.
- Affiliations
- National Institute for Medical Research (GB)
- Inserm (FR)
- Imperial College Healthcare NHS Trust (GB)
- University of Cape Town (ZA)
- The University of Texas Southwestern Medical Center (US)
- Baylor Scott & White Health (US)
- Nationwide Children's Hospital (US)
- Corresponding author
- O’Garra, Anne
- ORCID
- Venue
- Nature
- Published
- 2010-08
- Volume
- 466
- Issue
- 7309
- Pages
- 973-977
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3492754
- OpenAlex
- W2109543073
- Cited by
- 1,898
- References
- 29
- Citations by year
- 2026: 104 · 2025: 105 · 2024: 112 · 2023: 108 · 2022: 99 · 2021: 121 · 2020: 113 · 2019: 127 · 2018: 137 · 2017: 134 · 2016: 149 · 2015: 126 · 2014: 119 · 2013: 127 · 2012: 114
- FWCI
- 70.93
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Wellcome Trust (088316, 84323)
- Imperial College Healthcare NHS Trust
- U.S. Public Health Service (U19 AIO57234-02, P50 ARO54083)
- Medical Research Council
- National Cancer Institute (P01CA084512)
- National Institute of Allergy and Infectious Diseases (U19AI057234, U01AI082110, U19AI082715)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR050770, P50AR054083)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
- Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
- Keywords
- tuberculosis, Mycobacterium tuberculosis, latent tuberculosis infection, active tuberculosis, whole blood transcriptome, interferon-stimulated genes, neutrophils, interferon-gamma signaling, type I interferon, transcriptomic biomarkers, diagnostic biomarkers, prognostic factors, systemic lupus erythematosus, cell composition, treatment response monitoring
- MeSH terms
- Blood, Gene Expression Regulation, Humans, Interferon Type I, Lupus Erythematosus, Systemic, Mycobacterium tuberculosis, Neutrophils, Transcription, Genetic, Tuberculosis, Tuberculosis, Pulmonary, Signal Transduction, Case-Control Studies, Gene Expression Profiling, Latent Tuberculosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
